This report focuses on the global Induced Pluripotent Stem Cells (iPSCs) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Induced Pluripotent Stem Cells (iPSCs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL
Market segment by Type, the product can be split into
Human iPSCs
Mouse iPSCs
Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs.
Market segment by Application, split into
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Academic Research is the largest segment of Induced Pluripotent Stem Cells (iPSCs) application,with a share of 32% in 2018.
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Induced Pluripotent Stem Cells (iPSCs) status, future forecast, growth opportunity, key market and key players.
To present the Induced Pluripotent Stem Cells (iPSCs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Induced Pluripotent Stem Cells (iPSCs) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The key players covered in this study
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL
Market segment by Type, the product can be split into
Human iPSCs
Mouse iPSCs
Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs.
Market segment by Application, split into
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Academic Research is the largest segment of Induced Pluripotent Stem Cells (iPSCs) application,with a share of 32% in 2018.
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Induced Pluripotent Stem Cells (iPSCs) status, future forecast, growth opportunity, key market and key players.
To present the Induced Pluripotent Stem Cells (iPSCs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Induced Pluripotent Stem Cells (iPSCs) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type (2014-2025)
1.4.2 Human iPSCs
1.4.3 Mouse iPSCs
1.5 Market by Application
1.5.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2019-2025)
1.5.2 Academic Research
1.5.3 Drug Development and Discovery
1.5.4 Toxicity Screening
1.5.5 Regenerative Medicine
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Induced Pluripotent Stem Cells (iPSCs) Market Size
2.2 Induced Pluripotent Stem Cells (iPSCs) Growth Trends by Regions
2.2.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (2019-2025)
2.2.2 Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by by Players
3.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by by Players (2014-2019)
3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by by Players (2014-2019)
3.1.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio (CR5 and HHI)
3.2 Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Area Served
3.3 Key Players Induced Pluripotent Stem Cells (iPSCs) Product/Solution/Service
3.4 Date of Enter into Induced Pluripotent Stem Cells (iPSCs) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2014-2019)
4.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2014-2019)
5 North America
5.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
5.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in North America
5.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
5.4 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
6 Europe
6.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
6.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Europe
6.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
6.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
7 China
7.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
7.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in China
7.3 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
7.4 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
8 Japan
8.1 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
8.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Japan
8.3 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
8.4 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
9.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Southeast Asia
9.3 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
9.4 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
10 India
10.1 India Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
10.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in India
10.3 India Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
10.4 India Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
11 Central & South America
11.1 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
11.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Central & South America
11.3 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
11.4 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
12 International Players Profiles
12.1 Fujifilm Holding Corporation (CDI)
12.1.1 Fujifilm Holding Corporation (CDI) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
12.1.4 Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019))
12.1.5 Fujifilm Holding Corporation (CDI) Recent Development
12.2 Ncardia
12.2.1 Ncardia Company Details
12.2.2 Company Description and Business Overview
12.2.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
12.2.4 Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
12.2.5 Ncardia Recent Development
12.3 Sumitomo Dainippon Pharma
12.3.1 Sumitomo Dainippon Pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
12.3.4 Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
12.3.5 Sumitomo Dainippon Pharma Recent Development
12.4 Astellas Pharma Inc
12.4.1 Astellas Pharma Inc Company Details
12.4.2 Company Description and Business Overview
12.4.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
12.4.4 Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
12.4.5 Astellas Pharma Inc Recent Development
12.5 Fate Therapeutics, Inc
12.5.1 Fate Therapeutics, Inc Company Details
12.5.2 Company Description and Business Overview
12.5.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
12.5.4 Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
12.5.5 Fate Therapeutics, Inc Recent Development
12.6 Pluricell Biotech
12.6.1 Pluricell Biotech Company Details
12.6.2 Company Description and Business Overview
12.6.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
12.6.4 Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
12.6.5 Pluricell Biotech Recent Development
12.7 Cell Inspire Biotechnology
12.7.1 Cell Inspire Biotechnology Company Details
12.7.2 Company Description and Business Overview
12.7.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
12.7.4 Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
12.7.5 Cell Inspire Biotechnology Recent Development
12.8 ReproCELL
12.8.1 ReproCELL Company Details
12.8.2 Company Description and Business Overview
12.8.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
12.8.4 ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
12.8.5 ReproCELL Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type (2014-2025)
1.4.2 Human iPSCs
1.4.3 Mouse iPSCs
1.5 Market by Application
1.5.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2019-2025)
1.5.2 Academic Research
1.5.3 Drug Development and Discovery
1.5.4 Toxicity Screening
1.5.5 Regenerative Medicine
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Induced Pluripotent Stem Cells (iPSCs) Market Size
2.2 Induced Pluripotent Stem Cells (iPSCs) Growth Trends by Regions
2.2.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (2019-2025)
2.2.2 Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by by Players
3.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by by Players (2014-2019)
3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by by Players (2014-2019)
3.1.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio (CR5 and HHI)
3.2 Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Area Served
3.3 Key Players Induced Pluripotent Stem Cells (iPSCs) Product/Solution/Service
3.4 Date of Enter into Induced Pluripotent Stem Cells (iPSCs) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2014-2019)
4.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2014-2019)
5 North America
5.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
5.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in North America
5.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
5.4 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
6 Europe
6.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
6.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Europe
6.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
6.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
7 China
7.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
7.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in China
7.3 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
7.4 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
8 Japan
8.1 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
8.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Japan
8.3 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
8.4 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
9.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Southeast Asia
9.3 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
9.4 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
10 India
10.1 India Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
10.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in India
10.3 India Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
10.4 India Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
11 Central & South America
11.1 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
11.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Central & South America
11.3 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
11.4 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
12 International Players Profiles
12.1 Fujifilm Holding Corporation (CDI)
12.1.1 Fujifilm Holding Corporation (CDI) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
12.1.4 Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019))
12.1.5 Fujifilm Holding Corporation (CDI) Recent Development
12.2 Ncardia
12.2.1 Ncardia Company Details
12.2.2 Company Description and Business Overview
12.2.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
12.2.4 Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
12.2.5 Ncardia Recent Development
12.3 Sumitomo Dainippon Pharma
12.3.1 Sumitomo Dainippon Pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
12.3.4 Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
12.3.5 Sumitomo Dainippon Pharma Recent Development
12.4 Astellas Pharma Inc
12.4.1 Astellas Pharma Inc Company Details
12.4.2 Company Description and Business Overview
12.4.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
12.4.4 Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
12.4.5 Astellas Pharma Inc Recent Development
12.5 Fate Therapeutics, Inc
12.5.1 Fate Therapeutics, Inc Company Details
12.5.2 Company Description and Business Overview
12.5.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
12.5.4 Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
12.5.5 Fate Therapeutics, Inc Recent Development
12.6 Pluricell Biotech
12.6.1 Pluricell Biotech Company Details
12.6.2 Company Description and Business Overview
12.6.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
12.6.4 Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
12.6.5 Pluricell Biotech Recent Development
12.7 Cell Inspire Biotechnology
12.7.1 Cell Inspire Biotechnology Company Details
12.7.2 Company Description and Business Overview
12.7.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
12.7.4 Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
12.7.5 Cell Inspire Biotechnology Recent Development
12.8 ReproCELL
12.8.1 ReproCELL Company Details
12.8.2 Company Description and Business Overview
12.8.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
12.8.4 ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
12.8.5 ReproCELL Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
